Merck Buys Millipore
Millipore Corporation, a leading life science company, and Merck & Co. Inc., a global pharmaceutical and chemicals company, entered into a definitive agreement under which Merck will acquire all outstanding shares of common stock of Millipore for US$107 per share in cash, or a total transaction value, including net debt, of approximately €5.3 billion (US$7.2 [...]
China Trials 2009